Mathematical modeling unveils the timeline of CAR-T cell therapy and macrophage-mediated cytokine release syndrome
PLOS Computational Biology · 09.04.2025 · 21 (4) · e1012908
DOI: 10.1371/journal.pcbi.1012908 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, online erschienen am 09.04.2025. Verfasst von Daniela S Santurio und 3 weiteren Autor:innen. Beteiligte Einrichtung: Certara UK Ltd., Sheffield, United Kingdom. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Cytokine Release Syndrome, Macrophages, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alexander von Humboldt Foundation, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES).
Abstract (Originalsprache)
Chimeric antigen receptor (CAR)-T cell therapy holds significant potential for cancer treatment, although disease relapse and cytokine release syndrome (CRS) remain as frequent clinical challenges. To better understand the mechanisms underlying the temporal dynamics of CAR-T cell therapy response and CRS, we developed a novel multi-layer mathematical model incorporating antigen-mediated CAR-T cell expansion, antigen-negative resistance, and macrophage-associated cytokine release. Three key mechanisms of macrophage activation are considered: release of damage-associated molecular patterns, antigen-binding mediated activation, and CD40-CD40L contact. The model accurately describes 25 patient time courses with different responses and IL-6 cytokine kinetics. We successfully link the dynamic shape of the response to interpretable model parameters and investigate the influence of CAR-T cell dose and initial tumor burden on the occurrence of cytokine release and treatment outcome. By disentangling the timeline of macrophage activation, the model identified distinct contributions of each activation mechanism, suggesting the CD40-CD40L axis as a major driver of cytokine release and a clinically feasible target to control the activation process and modulate cytokine peak height. Our multi-layer model provides a comprehensive framework for understanding the complex interactions between CAR-T cells, tumor cells, and macrophages during therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Certara UK Ltd., Sheffield, United Kingdom.
- Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil.
- Institute for Medical Informatics and Biometry, Technische Universität Dresden, Dresden, Germany.
- Instituto de Matemática e Computação, Universidade Federal de Itajubá, Itajubá, Brazil.
ORCID-Profile: Artur C Fassoni
Förderung
- Alexander von Humboldt Foundation
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES)
Zitieren
APA
Santurio, D. S., Barros, L. R. C., Glauche, I., & Fassoni, A. C. (2025). Mathematical modeling unveils the timeline of CAR-T cell therapy and macrophage-mediated cytokine release syndrome. PLOS Computational Biology, 21(4), e1012908. https://doi.org/10.1371/journal.pcbi.1012908
Vancouver
Santurio DS, Barros LRC, Glauche I, Fassoni AC. Mathematical modeling unveils the timeline of CAR-T cell therapy and macrophage-mediated cytokine release syndrome. PLOS Computational Biology. 2025;21(4):e1012908. doi:10.1371/journal.pcbi.1012908
BibTeX
@article{Santurio2025,
author = {Santurio, Daniela S and Barros, Luciana R C and Glauche, Ingmar and Fassoni, Artur C},
title = {Mathematical modeling unveils the timeline of CAR-T cell therapy and macrophage-mediated cytokine release syndrome},
journal = {PLOS Computational Biology},
year = {2025},
volume = {21},
number = {4},
pages = {e1012908},
doi = {10.1371/journal.pcbi.1012908}
}
EUVIMED